Great post as usual CYou have a great handle as usual on the...

First 5315 Last

Share
Profile

Follow
thevinnys

1,958 Posts.

4359

24/04/21

13:44

Post #: 52697752
Share

Originally posted by comincon: ↑

It hasn't been mooted yet from the IHL team but I suspect it isn't far away, particularly after the most recent announcement regarding the 'lung inflammation development program' and the 'process of designing a phase 1 clinical trial necessary to assess these conditions in-human with the purpose to form part of three distinct investigational new drug
applications (‘INDs’) and their associated studies required for registration and marketing authority. The
Company will update ASX when the development outline is finalised'

Mooted what ?
Acute Myocarditis / cardiovascular disease (CVD) ( inflammatory condition of the heart ) must surely be on the IHL teams radar now after the wonderful Phase 1 outcomes achieved by Cardiol.
'acute myocarditis, an inflammatory condition of the heart, which remains a leading cause of sudden cardiac death in children and young adults.”
Their randomised, placebo controlled double blind achieved 'topline results'...something that Im sure won't be lost on the FDA once their application is filed.

Link
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™ - Technical420 | Technical420

Dig in and have a read - well worth it in light of IHLs' wonderful news this week. Very exciting time to be holder in such a world class team that IHL is proving itself to be.

Views are my own as always open to the scrutiny of all who may be interested.

GLA

Expand

Great post as usual C

You have a great handle as usual on the development programs for Cannabidiol formulations.

Phase 1 for the Lung Inflammation Program (IHL-675A) is a very exciting prospect.

I couldn't agree more with your analysis of acute myocarditis. I hope we here some news from the BOD too!

BTW, I found this great infographic mapping the road ahead for IHL-675A.

GLAH

IHL Price at posting: 26.0¢ Sentiment: Buy Disclosure: Held
15 Upvote

2 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

DRE

Dreadnought (ASX:DRE) reports gold hit above 27 grams per tonne

TON

Triton snaffles 588 square km gold-copper play in Mozambique

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals